Androgen receptor–induced lncRNA SOX2-OT promotes triple-negative breast cancer tumorigenesis via targeting miR-320a-5p–CCR5 axis
Journal of Biological Chemistry · 2025
DOI: 10.1016/j.jbc.2025.108428 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Yixuan Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: MicroRNAs, Triple Negative Breast Neoplasms, Receptors, Androgen, RNA, Long Noncoding. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Province Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Our previous study showed that androgen receptor (AR) promotes triple-negative breast cancer (TNBC) cell tumorigenesis, but the underlying mechanisms remain unclear. Herein, using microarray analysis of long noncoding RNA expression profiles, we identified an AR-related long noncoding RNA SOX2-OT in TNBC. We found that AR could promote TNBC tumorigenesis by acting as a transcription factor to activate the expression of SOX2-OT. Mechanistic analysis demonstrated that SOX2-OT serves as a molecular sponge for miR-320a-5p to regulate the expression of CCR5. In addition, SOX2-OT promotes TNBC cell proliferation and inhibits apoptosis in an miR-320a-5p-dependent manner. Using a xenograft mouse model, we found that SOX2-OT-CCR5 axis could promote TNBC tumorigenesis in vivo. Importantly, the AR-SOX2-OT-miR-320a-5p-CCR5 axis is manifested in the tissues of 165 TNBC patients. Collectively, our results suggest that SOX2-OT can regulate AR-induced TNBC tumorigenesis through the miR-320a-5p-CCR5 signaling axis and reveal the great potential of targeting SOX2-OT for the treatment of TNBC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
- Department of Medical Oncology of PLA Cancer Center, Jinling Hospital, Nanjing, China.
- Department of Medical Oncology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- Department of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, PR China. Electronic address: jessicayy8629@126.com.
- Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Electronic address: wwzhang1022@hotmail.com.
Förderung
- Jiangsu Province Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Hu, Y., Bian, J., Chen, W., Shi, J., Wei, X., Du, Y., & Zhang, W. (2025). Androgen receptor–induced lncRNA SOX2-OT promotes triple-negative breast cancer tumorigenesis via targeting miR-320a-5p–CCR5 axis. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.108428
Vancouver
Hu Y, Bian J, Chen W, Shi J, Wei X, Du Y, et al. Androgen receptor–induced lncRNA SOX2-OT promotes triple-negative breast cancer tumorigenesis via targeting miR-320a-5p–CCR5 axis. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.108428
BibTeX
@article{Hu2025,
author = {Hu, Yixuan and Bian, Jin and Chen, Weiwei and Shi, Junfeng and Wei, Xiaowei and Du, Yueyao and Zhang, Wenwen},
title = {Androgen receptor–induced lncRNA SOX2-OT promotes triple-negative breast cancer tumorigenesis via targeting miR-320a-5p–CCR5 axis},
journal = {Journal of Biological Chemistry},
year = {2025},
doi = {10.1016/j.jbc.2025.108428}
}
EUVIMED